Prognostic value of plasma sAXL in patients with heart failure: insights from the DRAGON‐HF trial

BACKGROUND: Little is known about the predictive value of soluble AXL (sAXL) in heart failure (HF). This study aimed to describe the prognostic value of plasma sAXL in patients with symptomatic HF. METHODS: This is a multicentre observational prospective cohort study (Registration No. NCT03727828)....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yifan, Wang, Xiaoyu, Pan, Xin, Ma, Teng, Xu, Yawei, Fen, Qimao, Nijiati, Muyesai, Chi, Chen, Su, Yang, Zhang, Xianling, Xu, Dachun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871665/
https://www.ncbi.nlm.nih.gov/pubmed/36436827
http://dx.doi.org/10.1002/ehf2.14241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871665/
https://www.ncbi.nlm.nih.gov/pubmed/36436827
http://dx.doi.org/10.1002/ehf2.14241

Ejemplares similares